Institut Curie is recruiting 12 PhD students through its international program called EuReCa (Europe, Resarch & Care).

This program, part funded by the European Commission’s MSCA COFUND scheme, provides PhD students with a 3-year doctoral contract, a high level interdisciplinary, inter-sectorial, as well as international training and coaching sessions with personalized career development plans, secondments and mentoring.


PhD research projects in life sciences cover Institut Curie’s main research domains:

✓ Biology & Chemistry of Radiations, Cell Signaling & Cancer

✓ Development, Cancer, Genetics & Epigenetics

✓ Integrative Tumour Biology, Immunology & Environment

✓ Multiscale Physics-Biology-Chemistry & Cancer

✓ Translational Research


Institut Curie brings together a world-class multidisciplinary cancer research center and a model hospital group in Paris and surroundings. By embracing cross-disciplinary approaches, it drives the discovery of more effective treatments and leads to improved patient care.


Covid-19 notice: Please note that the entire recruitment process will be done online and all necessary precautions will be taken on arrival according to the sanitary situation in September 2021.


Open positions


  • Project 1

Acentrosomal microtubule organization in neural stem cells

Thesis supervisor(s): Alexandre Baffet

Research group: Cell Biology of Mammalian Neurogenesis


  • Project 2

Deciphering the role of transcription-replication conflict and R-loop in causing genome instability in breast cancer

Thesis supervisor(s): Chunlong Chen

Research group: Replication Program and Genome Instability


  • Project 3

Extracellular Vesicles in invasion, metastasis and ferroptosis resistance: a specific role for CD133/Prominin in aggressive gastrointestinal carcinoma

Thesis supervisor(s): Gisela D’Angelo & Sarah Watson

Research group: Structure and Membrane Compartments


  • Project 4

A multidisciplinary approach to determine the 3-dimensional organization of centromeres in mitosis

Thesis supervisor(s): Ines Drinnenberg

Research group: Evolution of Centromeres and Chromosome Segregation


  • Project 5

Characterization of the functions of protein arginine methyltransferase 4 (PRMT4/CARM1) in triple-negative breast cancers

Thesis supervisor(s): Thierry Dubois

Research group: Breast Cancer Biology


  • Project 6

Novel chemical tools to study base-excision DNA repair

Thesis supervisor(s): Anton Granzhan & Sophie Bombard

Research group: Chemistry for Nucleic Acid Recognition


  • Project 7

Control of gut development and physiology by cytokine signaling

Thesis supervisor(s): Pedro Hernandez

Research group: Development and Homeostasis of Mucosal Tissues


  • Project 8

Immune and epigenetic biomarkers assessments based on a basket prospective trial with Pembrolizumab and Vorinostat in patients with late stage squamous cell carcinoma

Thesis supervisor(s): Christophe Le Tourneau & Nicolas Servant

Research group: Bioinformatics and Computational Systems Biology of Cancer


  • Project 9

Mechanotransduction at the Golgi apparatus

Thesis supervisor(s): Jean-Baptiste Manneville & Stéphanie Miserey-Lenkei

Research group: Molecular Mechanisms of Intracellular Transport


  • Project 10

Identification and targeting of lncRNA sequence motifs regulating melanoma oncogenesis

Thesis supervisor(s): Alena Shkumatava

Research group: LincRNAs in Vertebrate Development


  • Project 11

Genetic determinants of tumor microenvironment in high grade serous ovarian carcinomas

Thesis supervisor(s): Marc-Henri Stern & Manuel Rodrigues

Research group: DNA Repair and Uveal Melanoma


  • Project 12

Comparative mechanisms of spindle assembly dynamics and scaling

Thesis supervisor(s): Phong Tran & François Nedelec

Research group: Cytoskeletal Architecture and Cell Morphogenesis


Eligibility criteria

  1. Early-stage researchers (ESR) shall at the call deadline be in the first four years (full-time equivalent research experience) of their research careers and have not been awarded a doctoral degree.
    Full-time equivalent research experience is measured from the date when a researcher obtained the degree which would formally entitle him or her to embark on a doctorate.
  2. Applicants may not have resided or carried out their main activity (work, studies, etc.) in France for more than 12 months in the 3 years prior to January 14th, 2021.
    Time spent as part of a procedure for obtaining refugee status under the Geneva Convention, compulsory national service and/ or short stays such as holidays are not taken into account.
  3. Applicants must be in possession of a European master degree or equivalent master’s degree which would formally entitle them to embark on a doctorate.


Selection process

Application deadline: January 14th, 2021 at 4:00pm (CET)

Candidates have to complete an online form in English in time via the web-based application portal. Applications will be evaluated through a three-step process:

  • Eligibility check of applications in Jan.-Feb. 2021
  • 1stround selection: Evaluation & ranking of applications by the Review Board in March-April 2021
  • 2ndround selection: Shortlisted candidates are invited for an online interview session by the Selection Committee in May 19-21, 2021.

Final results will be given in June 2021. Start of PhD on September 1st, 2021.


Additional comments

The EuReCa PhD Program is in English.

International students willing to apply for the EuReCa PhD Program should inquire about the visa procedure regarding their country.

Web site for application & more details:

Please indicate that you saw this advert on The French Society for Cell Biology website when applying.


This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie actions grant agreement no. 847718.


About the employer

  • The mission of Institut Curie’s Research Centre is to understand the complex workings of both normal and cancerous cells in their environment in an effort to find innovative and increasingly effective therapeutic approaches.